Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| 1 |
Apple
AAPL
|
+$1.37B |
| 2 |
Schwab Intermediately-Term US Treasury ETF
SCHR
|
+$1.24B |
| 3 |
Chevron
CVX
|
+$472M |
| 4 |
Pfizer
PFE
|
+$372M |
| 5 |
Amazon
AMZN
|
+$369M |
Top Sells
| 1 |
Schwab US Large- Cap ETF
SCHX
|
+$9.58B |
| 2 |
Schwab 5-10 Year Corporate Bond ETF
SCHI
|
+$5.28B |
| 3 |
Schwab International Equity ETF
SCHF
|
+$4.53B |
| 4 |
Schwab U.S Small- Cap ETF
SCHA
|
+$4.13B |
| 5 |
Schwab Emerging Markets Equity ETF
SCHE
|
+$2.63B |
Sector Composition
| 1 | Technology | 22.61% |
| 2 | Financials | 12.09% |
| 3 | Healthcare | 10.58% |
| 4 | Consumer Discretionary | 9.24% |
| 5 | Industrials | 8.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Orion
OEC
$521M
| $15.6M | ﹤0.01% |
875,275
+34,183
| +4% | +$609K |
|
1827
Green Plains
GPRE
$631M
| $15.6M | ﹤0.01% |
1,150,738
+159,147
| +16% | +$2.15M |
|
1828
Deluxe
DLX
$881M
| $15.6M | ﹤0.01% |
799,421
-138,501
| -15% | -$2.7M |
|
1829
Informatica
INFA
$7.55B
| $15.6M | ﹤0.01% |
615,958
+237,876
| +63% | +$6.01M |
|
1830
Triumph Financial, Inc.
TFIN
$1.4B
| $15.6M | ﹤0.01% |
195,532
+7,021
| +4% | +$558K |
|
1831
PAR Technology
PAR
$1.79B
| $15.5M | ﹤0.01% |
298,067
+20,811
| +8% | +$1.08M |
|
1832
Koppers
KOP
$567M
| $15.5M | ﹤0.01% |
424,871
+20,586
| +5% | +$752K |
|
1833
CAE Inc
CAE
$8.47B
| $15.4M | ﹤0.01% |
821,636
-2,150
| -0.3% | -$40.4K |
|
1834
Beam Therapeutics
BEAM
$2.08B
| $15.4M | ﹤0.01% |
629,492
+36,226
| +6% | +$888K |
|
1835
National Vision
EYE
$1.82B
| $15.4M | ﹤0.01% |
1,412,292
+208,684
| +17% | +$2.28M |
|
1836
IES Holdings
IESC
$7.5B
| $15.3M | ﹤0.01% |
76,739
+1,158
| +2% | +$231K |
|
1837
Akero Therapeutics
AKRO
$3.48B
| $15.3M | ﹤0.01% |
532,596
-22,269
| -4% | -$639K |
|
1838
Flywire
FLYW
$1.63B
| $15.3M | ﹤0.01% |
931,914
+21,655
| +2% | +$355K |
|
1839
MRC Global
MRC
$1.23B
| $15.3M | ﹤0.01% |
1,198,164
-96,892
| -7% | -$1.23M |
|
1840
Marcus & Millichap
MMI
$1.26B
| $15.2M | ﹤0.01% |
384,775
+12,401
| +3% | +$491K |
|
1841
DoubleVerify
DV
$2.13B
| $15.2M | ﹤0.01% |
902,147
-452,271
| -33% | -$7.62M |
|
1842
Keros Therapeutics
KROS
$636M
| $15.1M | ﹤0.01% |
260,120
+32,492
| +14% | +$1.89M |
|
1843
Harmonic Inc
HLIT
$1.13B
| $15.1M | ﹤0.01% |
1,036,729
+34,405
| +3% | +$501K |
|
1844
Enact Holdings
ACT
$5.74B
| $15.1M | ﹤0.01% |
414,899
+68,808
| +20% | +$2.5M |
|
1845
A-Mark Precious Metals
AMRK
$664M
| $15.1M | ﹤0.01% |
341,208
-93,504
| -22% | -$4.13M |
|
|
NVEE
1846
DELISTED
NV5 Global
NVEE
| $15.1M | ﹤0.01% |
644,496
+24,752
| +4% | +$578K |
|
1847
SAP
SAP
$299B
| $15.1M | ﹤0.01% |
65,732
+12,948
| +25% | +$2.97M |
|
1848
Ichor Holdings
ICHR
$579M
| $15M | ﹤0.01% |
472,757
+26,951
| +6% | +$857K |
|
1849
Klaviyo
KVYO
$9.36B
| $15M | ﹤0.01% |
424,357
+91,824
| +28% | +$3.25M |
|
1850
Plug Power
PLUG
$1.76B
| $15M | ﹤0.01% |
6,637,039
+1,354,500
| +26% | +$3.06M |
|